Eur 1.8 million seed funding to progress its pipeline of cardiovascular disease targetsCompany appoints Nicky Cooper as its Chief Executive OfficerFinancing round co-led by FIRST Fund, KIKK Capital and Oost NL Enschede, The Netherlands, 20 January 2022 – River...
Joint Venture Partners Forbion and BioGeneration Ventures extend collaboration with Lonza to include services relating to small molecules for the portfolio companies of both entitiesThe collaboration continues to provide early de-risking, development and...
Amsterdam, The Netherlands, 17 December 2021 – NorthSea Therapeutics B.V., (‘NST’) a biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic diseases, today announces the close of a USD...
Ghent, Belgium, December 15, 2021 – Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that it has extended its patent estate with four key US and EU patents granted as part of the company’s...
Leiden, The Netherlands, 15 December 2021 – VarmX, a clinical-stage biotech company focusing on development of innovative approaches for the reversal of anticoagulation, today announced treatment of the first subjects in its first-in-human study for lead...
Expanded deal focuses on Synaffix’s GlycoConnect™ site-specific ADC bioconjugation technology and adds license options for six new programs to existing dealMersana currently developing two programs based on GlycoConnect™ site-specific ADC bioconjugation technology...
